Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks — Implications for coronavirus vaccine development

Human Vaccines and Immunotherapeutics

Volumn 13, Issue 1, 2017, Pages 186-189

  Ng, Oi Wing ^a   Tan, Yee Joo ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Bats; Emerging and re emerging virus; SARS like coronavirus; Severe acute respiratory syndrome coronavirus; Zoonotic virus

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CATHEPSIN L; CORONAVIRUS SPIKE GLYCOPROTEIN; PALIVIZUMAB; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; TEICOPLANIN; VIRUS RNA; ZMAPP; VIRUS VACCINE;

CELL CULTURE; CLONING; CORONAVIRUS INFECTION; DRUG DESIGN; EBOLA HEMORRHAGIC FEVER; GENE MUTATION; HUMAN; IMMUNOTHERAPY; METAGENOMICS; NONHUMAN; NOTE; RESPIRATORY TRACT DISEASE; SARS CORONAVIRUS; SEROLOGY; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; BAT; EPIDEMIC; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; REVERSE GENETICS; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY;

ANIMALS; CHIROPTERA; DISEASE OUTBREAKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; REVERSE GENETICS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL VACCINES;

EID: 84994807448     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1228500     Document Type: Note

References (29)

1. Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004; 10:S88-97; PMID:15577937; http://dx.doi.org/10.1038/nm1143
2. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (New York, NY) 2003; 302:276-8; http://dx.doi.org/10.1126/science.1087139
3. Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol 2005; 79:11892-900; PMID:16140765; http://dx.doi.org/10.1128/JVI.79.18.11892-11900.2005
4. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A 2005; 102:2430-5; PMID:15695582; http://dx.doi.org/10.1073/pnas.0409608102
5. Mokili JL, Rohwer F, Dutilh BE. Metagenomics and future perspectives in virus discovery. Curr Opin Virol 2012; 2:63-77; PMID:22440968; http://dx.doi.org/10.1016/j.coviro.2011.12.004
6. Willner D, Hugenholtz P. From deep sequencing to viral tagging:recent advances in viral metagenomics. BioEssays 2013; 35:436-42; PMID:23450659; http://dx.doi.org/10.1002/bies.201200174
7. Drexler JF, Corman VM, Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 2014; 101:45-56; PMID:24184128; http://dx.doi.org/10.1016/j.antiviral.2013.10.013
8. Almazan F, Sola I, Zuniga S, Marquez-Jurado S, Morales L, Becares M, Enjuanes L. Coronavirus reverse genetic systems:infectious clones and replicons. Virus Res 2014; 189:262-70; PMID:24930446; http://dx.doi.org/10.1016/j.virusres.2014.05.026
9. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310:676-9; http://dx.doi.org/10.1126/science.1118391
10. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 2005; 102:14040-5; PMID:16169905; http://dx.doi.org/10.1073/pnas.0506735102
11. Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV–a target for vaccine and therapeutic development. Nat Rev Microbiol 2009; 7:226-36; PMID:19198616; http://dx.doi.org/10.1038/nrmicro2090
12. Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang SY, Wang LF, Deng H, Shi Z. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J Virol 2008; 82:1899-907; PMID:18077725; http://dx.doi.org/10.1128/JVI.01085-07
13. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013; 503:535-8; PMID:24172901; http://dx.doi.org/10.1038/nature12711
14. Menachery VD, Yount BL, Jr., Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, et al. SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 2016; 113:3048-53; PMID:26976607; http://dx.doi.org/10.1073/pnas.1517719113
15. Menachery VD, Yount BL, Jr., Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 2015; 21:1508-13; PMID:26552008; http://dx.doi.org/10.1038/nm.3985
16. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014; 514:47-53; PMID:25171469
17. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Eng J Med 1993; 329:1524-30; PMID:8413475; http://dx.doi.org/10.1056/NEJM199311183292102
18. Coughlin MM, Prabhakar BS. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus:target, mechanism of action, and therapeutic potential. Rev Med Virol 2012; 22:2-17; PMID:21905149; http://dx.doi.org/10.1002/rmv.706
19. Elshabrawy HA, Coughlin MM, Baker SC, Prabhakar BS. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PloS One 2012; 7:e50366; PMID:23185609; http://dx.doi.org/10.1371/journal.pone.0050366
20. Ng OW, Keng CT, Leung CS, Peiris JS, Poon LL, Tan YJ. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody. PloS One 2014; 9:e102415; PMID:25019613; http://dx.doi.org/10.1371/journal.pone.0102415
21. Kilianski A, Baker SC. Cell-based antiviral screening against coronaviruses:developing virus-specific and broad-spectrum inhibitors. Antiviral Res 2014; 101:105-12; PMID:24269477; http://dx.doi.org/10.1016/j.antiviral.2013.11.004
22. Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir. Virology journal 2016; 13:87; PMID:27255185; http://dx.doi.org/10.1186/s12985-016-0544-0
23. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS:recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14(8):523-34; PMID:27344959
24. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Dis 2016; 15:327-47; PMID:26868298; http://dx.doi.org/10.1038/nrd.2015.37
25. Hui DS, Memish ZA, Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med 2014; 20:233-41; PMID:24626235; http://dx.doi.org/10.1097/MCP.0000000000000046
26. Cheng KW, Cheng SC, Chen WY, Lin MH, Chuang SJ, Cheng IH, Sun CY, Chou CY. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res 2015; 115:9-16; PMID:25542975; http://dx.doi.org/10.1016/j.antiviral.2014.12.011
27. Zhou N, Pan T, Zhang J, Li Q, Zhang X, Bai C, Huang F, Peng T, Zhang J, Liu C, et al. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). J Biol Chem 2016; 291:9218-32; PMID:26953343; http://dx.doi.org/10.1074/jbc.M116.716100
28. Zhao J, Zhao J, Mangalam AK, Channappanavar R, Fett C, Meyerholz DK, Agnihothram S, Baric RS, David CS, Perlman S. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity 2016; 44:1379-91; PMID:27287409; http://dx.doi.org/10.1016/j.immuni.2016.05.006
29. Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016; 24:490-502; PMID:27012512; http://dx.doi.org/10.1016/j.tim.2016.03.003